Comparison
3p Syndrome C4706503 vs 2 Hydroxyglutaric Aciduria C2746066
Clinical comparison between 3P Syndrome and 2 Hydroxyglutaric Aciduria for differential diagnosis and treatment planning.
3p Syndrome C4706503
A rare chromosomal disorder involving deletion of genetic material from chromosome 3. It causes distinctive facial features, growth delays, and intellectual disability. Care involves managing developmental and medical complications.
2 Hydroxyglutaric Aciduria C2746066
An organic acidemia where elevated acids accumulate in the body. It can cause neurological and developmental problems. Treatment focuses on supportive care and symptom management.
6 comparison axes
Onset
3p Syndrome C4706503
0-0
2 Hydroxyglutaric Aciduria C2746066
0-10
Onset patterns differ
Severity
3p Syndrome C4706503
severe
2 Hydroxyglutaric Aciduria C2746066
moderate
Different severity levels
Chronic
3p Syndrome C4706503
Chronic
2 Hydroxyglutaric Aciduria C2746066
Chronic
Differing course
Communicable
3p Syndrome C4706503
No
2 Hydroxyglutaric Aciduria C2746066
No
Different transmission
Body System
3p Syndrome C4706503
congenital
2 Hydroxyglutaric Aciduria C2746066
metabolic
Same/different system
Category
3p Syndrome C4706503
genetic
2 Hydroxyglutaric Aciduria C2746066
metabolic
Different category
Bottom line
3p-syndrome-C4706503 and 2-hydroxyglutaric-aciduria-C2746066 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3p Syndrome C4706503 | 2 Hydroxyglutaric Aciduria C2746066 | Discriminating power |
|---|---|---|---|
| Facial and growth features | Source describes distinctive facial features and growth delay from birth. | Facial or growth findings are not established by the supplied description. | Moderate |
| Neurologic development | Intellectual disability and developmental complications are described. | Neurological and developmental problems may occur, with variable severity. | Low |
| Metabolic accumulation | No organic-acid accumulation is described. | Elevated organic acids accumulate and define the metabolic process. | High |
When to favor each condition
Choose 3p Syndrome C4706503 when
Congenital dysmorphic and growth findings
Chromosomal deletion better fits a congenital genetic presentation.
Moderate
Suspected chromosome 3 deletion
Genetic testing is the appropriate diagnostic direction.
High
Severe congenital developmental disorder
The supplied severity is severe, but diagnosis still requires confirmation.
Low
Choose 2 Hydroxyglutaric Aciduria C2746066 when
Childhood neurologic or developmental concerns
Onset may extend through childhood rather than being limited to birth.
Moderate
Suspected organic acidemia
Metabolic testing can identify abnormal organic-acid accumulation.
High
Need for supportive metabolic care
Management is described as supportive and symptom-directed.
Moderate
How key tests differ
| Test | 3p Syndrome C4706503 | 2 Hydroxyglutaric Aciduria C2746066 | Interpretation |
|---|---|---|---|
| Chromosomal microarray or karyotype | May identify deletion involving chromosome 3. | Not expected to establish this metabolic disorder. | A positive chromosomal result supports 3p syndrome; clinician review is required. |
| Urine organic-acid analysis | No characteristic organic-acid pattern is described. | May show elevated 2-hydroxyglutaric acid; no cutoff is supplied. | An abnormal result is not itself a complete diagnosis. |
| Targeted metabolic or genetic testing | Directed toward chromosomal material rather than an enzyme pathway. | May clarify the metabolic subtype when clinically indicated. | Test selection should follow specialist assessment. |
Prognosis comparison
3p Syndrome C4706503
- Outcome
- A severe chronic congenital course is described, but individual outcome is not established.
- Factors
- Extent of deletion and associated medical complications may matter.
2 Hydroxyglutaric Aciduria C2746066
- Outcome
- A moderate chronic course is supplied, with possible neurologic effects.
- Factors
- Subtype, neurologic involvement, and response to supportive care may influence course.
Time frame: From birth or childhood into long-term follow-up; exact timelines are unavailable.
Prognosis should be individualized; no mortality or prevalence figures are provided.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental impairment | Intellectual disability and developmental complications are expected concerns. Neurological and developmental problems can occur. Severity and specific deficits are not fully established here. |
| Growth problems | Growth delay is described. Growth effects are not specified in the source. Do not infer a shared growth phenotype. |
| Medical complexity | Care addresses congenital developmental and medical complications. Care centers on supportive symptom management. Complication rates and mortality are not supplied. |
Patient education highlights
- HighDifferent causes
One is a chromosomal deletion; the other is an organic acidemia. Testing must match the suspected cause.
- HighAbnormal result versus diagnosis
An abnormal genetic or metabolic result needs clinician interpretation and confirmatory context.
- MediumLong-term care
Both are chronic and noncommunicable; care is individualized and supportive.